Justin Trojanowski's most recent trade in Tempest Therapeutics Inc was a trade of 30,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tempest Therapeutics Inc | Justin Trojanowski | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Tempest Therapeutics Inc | Justin Trojanowski | Corporate Controller | Purchase of securities on an exchange or from another person at price $ 2.16 per share. | 28 Jun 2024 | 7,500 | 22,168 | - | 2.2 | 16,200 | Common Stock |
| Tempest Therapeutics Inc | Justin Trojanowski | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 26,500 | 26,500 | - | - | Employee Stock Option (right to buy) | |
| Tempest Therapeutics Inc | Justin Trojanowski | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 20,300 | 20,300 | - | - | Employee Stock Option (right to buy) | |
| Tempest Therapeutics Inc | Justin Trojanowski | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 2,500 | 2,500 | - | - | Employee Stock Option (right to buy) |